Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chifeng Mysun Pharmaceutical is a specialized pharmaceutical manufacturer based in Chifeng, Inner Mongolia, China. The company focuses on the production of high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly in the fields of cardiovascular, emergency, and obstetric medicine. Its core product line includes critical care injectables such as epinephrine, norepinephrine, and oxytocin. Chifeng Mysun operates GMP-compliant facilities and serves as a significant supplier for both the Chinese domestic market and international export. The company is recognized for its expertise in small molecule synthesis and sterile injection manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chifeng Mysun Pharmaceutical.